BioSpace News Archive

Drug Development

Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial

Daewoong Pharmaceutical announced its phase 2B clinical trial topline results for Foistar, which is being developed as a treatment for COVID-19.

July 29, 2021
·
4 min read
Baylis Medical Announces First Clinical Use of the VersaCross® Large Access Solution to Deliver Large Bore Therapy Solutions

Baylis Medical announced the first clinical use of the VersaCross® Large Access Solution.

July 29, 2021
·
3 min read
Business

West Announces Second-Quarter 2021 Results

West Pharmaceutical Services, Inc. announced its financial results for the second-quarter 2021 and updated full-year 2021 financial guidance.

July 29, 2021
·
16 min read
Pharm Country

BD to Begin Remediation for BD Alaris™ System Software

BD, a leading global medical technology company, announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall through a new version of software.

July 29, 2021
·
4 min read
Business

Intercept Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, announced its financial results for the quarter ended June 30, 2021.

July 29, 2021
·
26 min read
Business

Evelo Biosciences Reports Second Quarter 2021 Financial Results and Business Highlights

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered medicines, reported financial results and business highlights for the second quarter 2021.

July 29, 2021
·
11 min read
Business

Agios Reports Business Highlights and Second Quarter 2021 Financial Results

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat genetically defined diseases, reported business highlights and financial results for the second quarter ended June 30, 2021.

July 29, 2021
·
10 min read
Biotech Bay

SI-BONE to Present at the Canaccord Genuity 41st Annual Growth Conference

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced that the company will be participating in the upcoming Canaccord Genuity 41st Annual Growth Conference.

July 29, 2021
·
1 min read
Business

Apellis Pharmaceuticals to Host Conference Call on August 9, 2021 to Discuss Second Quarter 2021 Financial Results

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced that the company will host a conference call and webcast to discuss its second quarter 2021 financial results on Monday, August 9, 2021 at 4:30 p.m. ET.

July 29, 2021
·
1 min read
Policy

Cepheid Receives CE-IVD Clearance for Two Next-Generation Xpert® HIV-1 Tests

Cepheid announced that it has received CE-IVD clearance for Xpert® HIV-1 Viral Load XC and Xpert® HIV-1 Qual XC, next-generation extended-coverage tests for HIV testing.

July 29, 2021
·
2 min read